Jul 242017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MA – Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on the development of potentially curative therapeutics using CRISPR technology, announced today the appointment of Moncef Slaoui, Ph.D.… => Read more

Intellia Therapeutics appoints Drs Moncef Slaoui and Frank Verwiel to its Board of Directors

From:: Intellia Therapeutics appoints Drs Moncef Slaoui and Frank Verwiel to its Board of Directors

Sorry, the comment form is closed at this time.

%d bloggers like this: